ReviewInternational journal of nanomedicine2019

CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties.

Lawrence D Mayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.